Hua Medicine (Shanghai) Ltd. (HUMDF) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Hua Medicine (Shanghai) Ltd.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
2.54
Strong
WeakModerateStrong
P/B Ratio
2.71
Strong
WeakModerateStrong
Earnings Yield
39.43%
Strong
WeakModerateStrong
Profitability Health
2025Return on Equity
107.04%
Strong
WeakModerateStrong
Operating Margin
-29.39%
Weak
WeakModerateStrong
Net Profit Margin
224.44%
Strong
WeakModerateStrong
Growth Indicators
2025Revenue Growth
87.66%
Strong
WeakModerateStrong
Net Income Growth
530.87%
Strong
WeakModerateStrong
EPS Growth
548.00%
Strong
WeakModerateStrong
Efficiency & Liquidity
2025Current Ratio
6.17
Strong
WeakModerateStrong
Quick Ratio
5.59
Strong
WeakModerateStrong
Asset Turnover
0.33x
Weak
WeakModerateStrong
Inventory Turnover
1.70x
Weak
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
-2.18%
Weak
WeakModerateStrong
EV / Free Cash Flow
-32.54x
Strong
WeakModerateStrong
Net Debt / EBITDA
7.22x
Weak
WeakModerateStrong
Interest Burden (EBT / EBIT)
-7.636
Weak
WeakModerateStrong
Return on Invested Capital
-10.78%
Weak
WeakModerateStrong
Cash Conversion Cycle
132.52 days
Weak
WeakModerateStrong
Fortress screener guardrails
0/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for HUMDF.
View Financial Statements